WCN26-4680 RENOPROTECTIVE EFFECT OF DOTINURAD IN PATIENTS WITH HYPERURICEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY

Read full text Summarise with VIRAT
Authors: Kazuki Amabe, Takumi Osugi, Taishi Kobayashi, Ayana Kunii, Arisa Nozaki, Kyoji Chiba, Jin Oshikawa
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Dotinurad is a novel selective urate reabsorption inhibitor that potently and selectively inhibits urate transporter 1 (URAT1) in the kidney. In addition to its urate-lowering action, recent studies have suggested its potential renoprotective effects, including reductions in urinary albumin excretion. However, clinical data on long-term renal outcomes remain limited. We aimed to evaluate the effects of dotinurad on renal function decline and proteinuria in patients with hyperuricemia.

Fields of Study & Subjects

Gout Hyperuricemia Uric Acid Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104341–104341
Publication date
25 March 2026
Language
EN